Taynãna César Simões

Taynãna César Simões

Auto-generated profile, based on publicly available information

Taynãna César Simões

Fundação Oswaldo Cruz, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
TSTaynãna César Simões
Taynãna César Simões
KMKarina Cardoso Meira
Karina Cardoso Meira
Juliano dos SantosJuliano dos Santos
Juliano dos Santos
DCDaniel Cardoso Portela Câmara
Daniel Cardoso Portela Câmara
Resumo As Doenças Crônicas Não Transmissíveis (DCNT) são as principais causas de morte no mundo, impactando fortemente sobre populações mais vulneráveis. O objetivo deste estudo foi analisar as mudanças nas prevalências dessas doenças, nas condições de saúde, acesso e utilização de serviços de saúde no Brasil, entre 2008 e 2019. Como ferramenta analítica, foram utilizados testes de diferenças de proporções e modelos lineares generalizados, considerando amostragem complexa dos inquéritos da Pesquisa Nacional por Amostra de Domicílios (PNAD) de 2008, e da Pesquisa Nacional de Saúde (PNS), nos anos de 2013 e 2019, para testar mudanças no tempo das prevalências e estimar razões de prevalência, ajustadas por variáveis sociodemográficas. Houve aumento das prevalências de depressão, câncer, diabetes, distúrbios neuropsiquiátricos, problemas pulmonares crônicos e problemas osteomusculares. Houve redução de artrite reumatoide, insuficiência renal crônica e doenças do aparelho circulatório. Entre os brasileiros com pelo menos uma DCNT verificou-se aumento da cobertura da Estratégia de Saúde da Família ao longo do tempo, no entanto verificou-se redução do atendimento médico em tempo oportuno e obtenção de medicamentos prescritos gratuitamente.

28 September 2018 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
TSTaynãna César Simões
Taynãna César Simões
LBLaiane Félix Borges
Laiane Félix Borges
AAAuzenda Conceição Parreira De Assis
Auzenda Conceição Parreira De Assis
MSMaria Vitórias Silva
Maria Vitórias Silva
JSJuliano Dos Santos
Juliano Dos Santos
KMKarina Cardoso Meira
Karina Cardoso Meira
Chagas disease (CD) is a neglected chronic parasitic infection and a public health problem that is preventable, and has serious complications. In this study, the effects of age, period and birth cohort (APC Effects) on the evolution of the mortality of that disease in Brazil, from 1980–2014, according to sex and geographic region of the country, were analyzed. Mortality forecasts from the years 2015 to 2034 were estimated. This is an ecological cross-sectional study in which death records and population data were extracted from the DATASUS (Department of Information Technology of the National Health System) website, in age groups from 20–24 years of age to 80 years and over, from 1980 to 2014. The rates were standardized according to age and sex distributions using the direct method. The APC models were estimated using the Bayesian approach, and the INLA (Integrated Nested Laplace Approximations) method was used for parameter inference. Super dispersion of the data was considered, and we included unstructured random terms in the models. During the analyzed period, there were 178,823 deaths in Brazil (3.85 annual deaths per 100,000 inhabitants). It was found that temporal effects on CD mortality varied by sex and region. In general, there was an increase in mortality rates up to 30 years of age, and the mortality rates were higher between 50 and 64 years of age. On average, men died five years younger than women. Mortality rates were highest in the Central West and Southeast regions. The Central West, Southeast and Southern regions had a reduction over time in the rate of CD deaths between 2000 and 2014. The mortality rate in the Northeast was not statistically different in any period analyzed, while the North had tendency to increase; however, a significant risk increase was only observed between 1995 and 1999. The rate of mortality was high in older birth cohorts. The overall prediction for the next two decades showed a progressive decline in CD mortality, which will be highest among the young. The expected average reduction was 76.1% compared to the last observed period (2010–2014) and the last predicted (2030–2034) period. The average reduction ranged from 86% in the 20–24 age group to 50% in the 80 and over age group. In the present study, a higher death rate was observed for ages above 30 years, especially 50 to 64 years, and in the older birth cohorts. We believe these results can be related to period effects of vector control actions and preventive and care measures by the health system of Brazil, in addition to demographic changes in the period. The differences among the regions reflect socioeconomic inequities and access to the healthcare systems in the Brazilian population. Chagas disease (CD) is a neglected chronic parasitic infection of great interest in public health, because it is preventable and has serious complications. In Brazil, despite the success obtained by controlling transmission by the T.infestans vector and by transfusion screening, the disease still affects more than 4 million people, with 6000 annual deaths. Studies that evaluate mortality from CD are an important indicator of the impact of the disease. However, studies in Brazil have not evaluated the effects of age, period and birth cohort (APC effects) separately to understand the importance and particularity of aspects related to the evolution of CD mortality over time. This study estimated the APC effects by sex and geographic region of Brazil in the period from 1980–2014 and estimated the mortality rates for two more decades (2015–2034). Using Bayesian hierarchical modeling, significant differences in temporal effects were found. The main findings were as follows: a) a progressive increase in the rate of CD death with increasing age, up to 30 years, with the highest mortality between 50 and 64 years; b) a generational effect, with a lower rate of death for younger cohorts; c) a reduction in the rate of CD death for the Central West, South and Southeast regions no statistical effect in the Northeast region, and increased risk in the North region since 2000; and d) a reduction in the mortality rates for the next 20 years, with rates being highest among the youngest age group. These results suggest the importance of the period effect on Chagas disease prevention and control measures, in addition to the expansion of health services access and the migration from endemic areas to non-endemic areas that has reduced population exposure to T.cruzi infection, especially in birth cohorts after the 1960s. In addition, differences among the regions of the country reflect the association of disease mortality with socioeconomic status, as well as inequities in access to healthcare by the Brazilian population.

28 November 2016 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
Eric CaragataEric Caragata
Eric Caragata
FRFernanda Oliveira Rezende
Fernanda Oliveira Rezende
TSTaynãna César Simões
Taynãna César Simões
LMLuciano Moreira
Luciano Moreira
The pathogen interference phenotype greatly restricts infection with dengue virus (DENV) and other pathogens in Wolbachia-infected Aedes aegypti, and is a vital component of Wolbachia-based mosquito control. Critically, the phenotype’s causal mechanism is complex and poorly understood, with recent evidence suggesting that the cause may be species specific. To better understand this important phenotype, we investigated the role of diet-induced nutritional stress on interference against DENV and the avian malarial parasite Plasmodium gallinaceum in Wolbachia-infected Ae. aegypti, and on physiological processes linked to the phenotype. Wolbachia-infected mosquitoes were fed one of four different concentrations of sucrose, and then challenged with either P. gallinaceum or DENV. Interference against P. gallinaceum was significantly weakened by the change in diet however there was no effect on DENV interference. Immune gene expression and H2O2 levels have previously been linked to pathogen interference. These traits were assayed for mosquitoes on each diet using RT-qPCR and the Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit, and it was observed that the change in diet did not significantly affect immune expression, but low carbohydrate levels led to a loss of ROS induction in Wolbachia-infected mosquitoes. Our data suggest that host nutrition may not influence DENV interference for Wolbachia-infected mosquitoes, but Plasmodium interference may be linked to both nutrition and oxidative stress. This pathogen-specific response to nutritional change highlights the complex nature of interactions between Wolbachia and pathogens in mosquitoes. Mosquito-transmitted disease severely impacts human health around the world. One novel form of control involves infecting medically important mosquito species with the naturally occurring bacterium Wolbachia, which restricts dengue and malaria transmission through a process called pathogen interference. The interference phenotype is still poorly understood, and potentially involves multiple physiological changes to the mosquito. We examined the role of nutritional stress on pathogen interference in the dengue vector Aedes aegypti, in order to better understand factors that might lead to variable interference. We demonstrated that interference against malaria-causing Plasmodium gallinaceum was dependent on mosquito nutritional status, however interference against dengue was not, implying that pathogen interference operates differently for different pathogens. We then examined mosquito immune processes that had been previously correlated with pathogen interference, and demonstrated that mosquito nutrition did not affect the expression of key mosquito immune genes, but did affect levels of reactive oxygen species. Our results highlight the complexity of the phenotype, and importantly suggest that adult nutrition may not be a key determinant of interference against DENV.

2 August 2018 in Revista Brasileira de Epidemiologia
Verified
Journal Article
Open access
PDF file
EDElislene Dias Drummond
Elislene Dias Drummond
TSTaynãna César Simões
Taynãna César Simões
FAFabíola Bof de Andrade
Fabíola Bof de Andrade
Palavras-chave: Assistência farmacêutica; Epidemiologia; Acesso a medicamentos

1 January 2020 in Revista Brasileira de Epidemiologia
Verified
Journal Article
Open access
PDF file
EDElislene Dias Drummond
Elislene Dias Drummond
TSTaynãna César Simões
Taynãna César Simões
FAFabíola Bof de Andrade
Fabíola Bof de Andrade
RESUMO: Objetivos: Avaliar a não adesão à farmacoterapia de doenças crônicas e investigar a existência de desigualdades socioeconômicas relacionadas a esse desfecho no Brasil. Métodos: Estudo realizado com base em dados da Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM), de 2014. A população de estudo correspondeu a indivíduos com 18 anos ou mais, com diagnóstico médico de pelo menos uma doença crônica e com indicação de tratamento farmacológico. A variável dependente foi a não adesão à farmacoterapia de doenças crônicas, mensurada pela adesão menor que 80% à terapia medicamentosa. Avaliou-se a desigualdade socioeconômica relacionada a não adesão pelos índices absoluto (SII) e relativo (RII) de desigualdade, calculados por análise de regressão logística. Resultados: A prevalência de não adesão à farmacoterapia no Brasil foi de 20,2%, variando de 17 a 27,8% entre as regiões. Além disso, esse estudo revelou desigualdades socioeconômicas absoluta e relativa na não adesão à farmacoterapia de doenças crônicas no Brasil (SII = -7,4; RII = 0,69) e nas regiões Nordeste (SII = -14; RII = 0,59) e Centro-Oeste (SII = -20,8; RII = 0,38). A probabilidade de não adesão à farmacoterapia, no Brasil, é maior entre os indivíduos de pior condição socioeconômica. Conclusão: Os achados do presente estudo apontam a necessidade de reestruturação e fortalecimento das políticas públicas voltadas à redução das desigualdades socioeconômicas em prol da promoção da equidade na adesão à farmacoterapia de doenças crônicas.

KMKarina Cardoso Meira
Karina Cardoso Meira
Carinne MagnagoCarinne Magnago
Carinne Magnago
AMAngelo Mendonça
Angelo Mendonça
SDStephane Fernanda Soares Duarte
Stephane Fernanda Soares Duarte
PFPedro Henrique Oliveira de Freitas
Pedro Henrique Oliveira de Freitas
TSTaynãna César Simões
Taynãna César Simões
Cervical cancer is a public health issue with high disease burden and mortality in Brazil. The objectives of the present study were, firstly, to analyze age, period, and cohort effects on cervical cancer mortality in women 20 years old or older from 1980 to 2019 in the North, South, and Southeast Regions of Brazil; and secondly, to evaluate whether the implementation of a national screening program and the expansion of access to public health services impacted the examined period and reduced the risk of death compared with previous years and among younger cohorts. The effects were estimated by applying Poisson regression models with estimable functions. The highest mortality rate per 100,000 women was found in Amazonas (24.13), and the lowest in São Paulo (10.56). A positive gradient was obtained for death rates as women’s age increased. The states in the most developed regions (South and Southeast) showed a reduction in the risk of death in the period that followed the implementation of the screening program and in the cohort from the 1960s onwards. The North Region showed a decreased risk of death only in Amapá (2000–2004) and Tocantins (1995–2004; 2010–2019). The findings indicate that health inequities remain in Brazil and suggest that the health system has limitations in terms of decreasing mortality associated with this type of cancer in regions of lower socioeconomic development.